Schläpfer, A. et al. 2020. The ’Holy Grail’ in Immuno-Oncology: AC BioScience SA is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning Strategy. CHIMIA. 74, 10 (Oct. 2020), 771. DOI:https://doi.org/10.2533/chimia.2020.771.